avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Spi1
|
ENSMUSG00000002111.8 | spleen focus forming virus (SFFV) proviral integration oncogene |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Spi1 | mm10_v2_chr2_+_91082362_91082390 | 0.83 | 2.9e-10 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_87793722 | 26.67 |
ENSMUST00000143021.2
|
Mpo
|
myeloperoxidase |
chr3_+_103832562 | 22.10 |
ENSMUST00000062945.5
|
Bcl2l15
|
BCLl2-like 15 |
chr11_+_87793470 | 21.52 |
ENSMUST00000020779.4
|
Mpo
|
myeloperoxidase |
chr7_-_127137807 | 20.18 |
ENSMUST00000049931.5
|
Spn
|
sialophorin |
chrX_-_7964166 | 20.14 |
ENSMUST00000128449.1
|
Gata1
|
GATA binding protein 1 |
chr3_-_90695706 | 20.11 |
ENSMUST00000069960.5
ENSMUST00000117167.1 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr7_-_142661858 | 19.78 |
ENSMUST00000145896.2
|
Igf2
|
insulin-like growth factor 2 |
chr8_+_72761868 | 16.33 |
ENSMUST00000058099.8
|
F2rl3
|
coagulation factor II (thrombin) receptor-like 3 |
chr2_+_84980458 | 15.57 |
ENSMUST00000028467.5
|
Prg2
|
proteoglycan 2, bone marrow |
chr6_-_40585783 | 15.11 |
ENSMUST00000177178.1
ENSMUST00000129948.2 ENSMUST00000101491.4 |
Clec5a
|
C-type lectin domain family 5, member a |
chr13_-_37049203 | 14.85 |
ENSMUST00000037491.8
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr5_+_90490714 | 14.84 |
ENSMUST00000042755.3
|
Afp
|
alpha fetoprotein |
chr8_-_85380964 | 14.81 |
ENSMUST00000122452.1
|
Mylk3
|
myosin light chain kinase 3 |
chr3_+_90669063 | 14.48 |
ENSMUST00000069927.8
|
S100a8
|
S100 calcium binding protein A8 (calgranulin A) |
chr15_+_78244781 | 14.33 |
ENSMUST00000096357.5
ENSMUST00000133618.1 |
Ncf4
|
neutrophil cytosolic factor 4 |
chr4_-_46404224 | 14.32 |
ENSMUST00000107764.2
|
Hemgn
|
hemogen |
chr14_-_56102458 | 14.09 |
ENSMUST00000015583.1
|
Ctsg
|
cathepsin G |
chr1_+_40515362 | 13.79 |
ENSMUST00000027237.5
|
Il18rap
|
interleukin 18 receptor accessory protein |
chr13_-_110357136 | 13.04 |
ENSMUST00000058806.5
|
Gapt
|
Grb2-binding adaptor, transmembrane |
chr10_+_127725392 | 12.82 |
ENSMUST00000026466.3
|
Tac2
|
tachykinin 2 |
chr19_-_11640828 | 12.75 |
ENSMUST00000112984.2
|
Ms4a3
|
membrane-spanning 4-domains, subfamily A, member 3 |
chr9_-_123968683 | 12.63 |
ENSMUST00000026911.4
|
Ccr1
|
chemokine (C-C motif) receptor 1 |
chr2_-_28084877 | 12.15 |
ENSMUST00000028179.8
ENSMUST00000117486.1 ENSMUST00000135472.1 |
Fcnb
|
ficolin B |
chr8_-_71723308 | 11.56 |
ENSMUST00000125092.1
|
Fcho1
|
FCH domain only 1 |
chr2_+_173022360 | 11.30 |
ENSMUST00000173997.1
|
Rbm38
|
RNA binding motif protein 38 |
chr16_+_32608973 | 10.91 |
ENSMUST00000120680.1
|
Tfrc
|
transferrin receptor |
chr4_-_118457450 | 10.85 |
ENSMUST00000106375.1
ENSMUST00000006556.3 ENSMUST00000168404.1 |
Mpl
|
myeloproliferative leukemia virus oncogene |
chr4_-_118457509 | 10.65 |
ENSMUST00000102671.3
|
Mpl
|
myeloproliferative leukemia virus oncogene |
chr14_+_80000292 | 10.60 |
ENSMUST00000088735.3
|
Olfm4
|
olfactomedin 4 |
chr7_-_17062384 | 10.08 |
ENSMUST00000153833.1
ENSMUST00000108492.2 |
Hif3a
|
hypoxia inducible factor 3, alpha subunit |
chr4_+_126556935 | 9.66 |
ENSMUST00000048391.8
|
Clspn
|
claspin |
chr10_+_79879614 | 9.56 |
ENSMUST00000006679.8
|
Prtn3
|
proteinase 3 |
chr2_+_173021902 | 9.50 |
ENSMUST00000029014.9
|
Rbm38
|
RNA binding motif protein 38 |
chr7_+_24370255 | 9.44 |
ENSMUST00000171904.1
|
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr5_-_107726017 | 9.42 |
ENSMUST00000159263.2
|
Gfi1
|
growth factor independent 1 |
chr12_-_32208609 | 9.41 |
ENSMUST00000053215.7
|
Pik3cg
|
phosphoinositide-3-kinase, catalytic, gamma polypeptide |
chr7_+_18884679 | 9.37 |
ENSMUST00000032573.6
|
Pglyrp1
|
peptidoglycan recognition protein 1 |
chr3_-_106167564 | 9.36 |
ENSMUST00000063062.8
|
Chi3l3
|
chitinase 3-like 3 |
chr1_+_135132693 | 9.31 |
ENSMUST00000049449.4
|
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chrX_-_102252154 | 9.17 |
ENSMUST00000050551.3
|
Cited1
|
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
chr7_-_127218303 | 9.14 |
ENSMUST00000106313.1
|
Sept1
|
septin 1 |
chr4_+_126556994 | 9.09 |
ENSMUST00000147675.1
|
Clspn
|
claspin |
chr1_+_134182150 | 9.09 |
ENSMUST00000156873.1
|
Chi3l1
|
chitinase 3-like 1 |
chr13_-_37050237 | 9.08 |
ENSMUST00000164727.1
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr16_-_42340595 | 9.03 |
ENSMUST00000102817.4
|
Gap43
|
growth associated protein 43 |
chr3_-_137981523 | 8.98 |
ENSMUST00000136613.1
ENSMUST00000029806.6 |
Dapp1
|
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
chr11_-_102469839 | 8.95 |
ENSMUST00000103086.3
|
Itga2b
|
integrin alpha 2b |
chr3_+_103832741 | 8.89 |
ENSMUST00000106822.1
|
Bcl2l15
|
BCLl2-like 15 |
chr4_-_133872304 | 8.85 |
ENSMUST00000157067.2
|
Rps6ka1
|
ribosomal protein S6 kinase polypeptide 1 |
chr16_+_32608920 | 8.84 |
ENSMUST00000023486.8
|
Tfrc
|
transferrin receptor |
chr17_+_29114142 | 8.83 |
ENSMUST00000141797.1
ENSMUST00000132262.1 ENSMUST00000141239.1 ENSMUST00000138816.1 |
Gm16194
|
predicted gene 16194 |
chr9_+_8544196 | 8.80 |
ENSMUST00000050433.6
|
Trpc6
|
transient receptor potential cation channel, subfamily C, member 6 |
chr2_+_164940742 | 8.70 |
ENSMUST00000137626.1
|
Mmp9
|
matrix metallopeptidase 9 |
chr14_-_51057242 | 8.59 |
ENSMUST00000089798.2
|
Rnase12
|
ribonuclease, RNase A family, 12 (non-active) |
chr7_-_100856289 | 8.45 |
ENSMUST00000139604.1
|
Relt
|
RELT tumor necrosis factor receptor |
chr6_+_124830217 | 8.44 |
ENSMUST00000131847.1
ENSMUST00000151674.1 |
Cdca3
|
cell division cycle associated 3 |
chrX_-_102251852 | 8.30 |
ENSMUST00000101336.3
ENSMUST00000136277.1 |
Cited1
|
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
chr11_+_32276400 | 8.20 |
ENSMUST00000020531.2
|
Hba-x
|
hemoglobin X, alpha-like embryonic chain in Hba complex |
chr14_+_27000362 | 8.09 |
ENSMUST00000035433.8
|
Hesx1
|
homeobox gene expressed in ES cells |
chr14_-_87141206 | 8.08 |
ENSMUST00000022599.7
|
Diap3
|
diaphanous homolog 3 (Drosophila) |
chr11_+_32286946 | 8.08 |
ENSMUST00000101387.3
|
Hbq1b
|
hemoglobin, theta 1B |
chr4_-_118620763 | 8.04 |
ENSMUST00000071972.4
|
Wdr65
|
WD repeat domain 65 |
chr10_+_79886302 | 8.03 |
ENSMUST00000046091.5
|
Elane
|
elastase, neutrophil expressed |
chr15_+_84324716 | 8.02 |
ENSMUST00000023074.2
|
Parvg
|
parvin, gamma |
chr7_-_127218390 | 7.91 |
ENSMUST00000142356.1
ENSMUST00000106314.1 |
Sept1
|
septin 1 |
chr2_-_26360873 | 7.86 |
ENSMUST00000028294.6
|
Card9
|
caspase recruitment domain family, member 9 |
chr12_-_32208470 | 7.83 |
ENSMUST00000085469.5
|
Pik3cg
|
phosphoinositide-3-kinase, catalytic, gamma polypeptide |
chr11_+_11685909 | 7.81 |
ENSMUST00000065433.5
|
Ikzf1
|
IKAROS family zinc finger 1 |
chr14_-_79301623 | 7.80 |
ENSMUST00000022595.7
|
Rgcc
|
regulator of cell cycle |
chr9_-_109849440 | 7.75 |
ENSMUST00000112022.2
|
Camp
|
cathelicidin antimicrobial peptide |
chr7_-_100855403 | 7.71 |
ENSMUST00000156855.1
|
Relt
|
RELT tumor necrosis factor receptor |
chr6_+_60944472 | 7.71 |
ENSMUST00000129603.1
|
Mmrn1
|
multimerin 1 |
chr12_+_109734969 | 7.70 |
ENSMUST00000182268.1
ENSMUST00000181543.2 ENSMUST00000183116.1 |
Mirg
|
miRNA containing gene |
chr19_+_10015016 | 7.62 |
ENSMUST00000137637.1
ENSMUST00000149967.1 |
Rab3il1
|
RAB3A interacting protein (rabin3)-like 1 |
chr9_+_56089962 | 7.41 |
ENSMUST00000059206.7
|
Pstpip1
|
proline-serine-threonine phosphatase-interacting protein 1 |
chr7_-_45239108 | 7.40 |
ENSMUST00000033063.6
|
Cd37
|
CD37 antigen |
chr4_+_34893772 | 7.39 |
ENSMUST00000029975.3
ENSMUST00000135871.1 ENSMUST00000108130.1 |
Cga
|
glycoprotein hormones, alpha subunit |
chr3_-_109027600 | 7.31 |
ENSMUST00000171143.1
|
Fam102b
|
family with sequence similarity 102, member B |
chr17_+_34590162 | 7.30 |
ENSMUST00000173772.1
|
Gpsm3
|
G-protein signalling modulator 3 (AGS3-like, C. elegans) |
chr2_+_84988194 | 7.29 |
ENSMUST00000028466.5
|
Prg3
|
proteoglycan 3 |
chr9_+_65587149 | 7.29 |
ENSMUST00000134538.1
ENSMUST00000136205.1 |
Pif1
|
PIF1 5'-to-3' DNA helicase homolog (S. cerevisiae) |
chr2_-_126491566 | 7.27 |
ENSMUST00000040149.6
|
Atp8b4
|
ATPase, class I, type 8B, member 4 |
chr2_-_26021679 | 7.26 |
ENSMUST00000036509.7
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr12_-_78906929 | 7.08 |
ENSMUST00000021544.7
|
Plek2
|
pleckstrin 2 |
chr19_-_17356631 | 7.05 |
ENSMUST00000174236.1
|
Gcnt1
|
glucosaminyl (N-acetyl) transferase 1, core 2 |
chr7_-_45239041 | 6.88 |
ENSMUST00000131290.1
|
Cd37
|
CD37 antigen |
chr16_+_17980565 | 6.84 |
ENSMUST00000075371.3
|
Vpreb2
|
pre-B lymphocyte gene 2 |
chr1_-_45503282 | 6.71 |
ENSMUST00000086430.4
|
Col5a2
|
collagen, type V, alpha 2 |
chr14_+_53763083 | 6.70 |
ENSMUST00000180859.1
ENSMUST00000103589.4 |
Trav14-3
|
T cell receptor alpha variable 14-3 |
chr15_-_66969616 | 6.68 |
ENSMUST00000170903.1
ENSMUST00000166420.1 ENSMUST00000005256.6 ENSMUST00000164070.1 |
Ndrg1
|
N-myc downstream regulated gene 1 |
chr2_-_26021532 | 6.68 |
ENSMUST00000136750.1
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr17_+_48454891 | 6.67 |
ENSMUST00000074574.6
|
Unc5cl
|
unc-5 homolog C (C. elegans)-like |
chr5_+_115845229 | 6.67 |
ENSMUST00000137952.1
ENSMUST00000148245.1 |
Cit
|
citron |
chr7_-_141016892 | 6.61 |
ENSMUST00000081924.3
|
Ifitm6
|
interferon induced transmembrane protein 6 |
chr14_+_55765956 | 6.57 |
ENSMUST00000057569.3
|
Ltb4r1
|
leukotriene B4 receptor 1 |
chr1_+_134182404 | 6.52 |
ENSMUST00000153856.1
ENSMUST00000082060.3 ENSMUST00000133701.1 ENSMUST00000132873.1 |
Chi3l1
|
chitinase 3-like 1 |
chr2_+_127336152 | 6.50 |
ENSMUST00000028846.6
|
Dusp2
|
dual specificity phosphatase 2 |
chr15_-_55090422 | 6.49 |
ENSMUST00000110231.1
ENSMUST00000023059.6 |
Dscc1
|
defective in sister chromatid cohesion 1 homolog (S. cerevisiae) |
chr16_-_75909272 | 6.48 |
ENSMUST00000114239.2
|
Samsn1
|
SAM domain, SH3 domain and nuclear localization signals, 1 |
chr17_-_48146306 | 6.47 |
ENSMUST00000063481.7
|
9830107B12Rik
|
RIKEN cDNA 9830107B12 gene |
chr7_+_142460809 | 6.43 |
ENSMUST00000105968.1
|
Lsp1
|
lymphocyte specific 1 |
chr7_-_100863373 | 6.42 |
ENSMUST00000142885.1
ENSMUST00000008462.3 |
Relt
|
RELT tumor necrosis factor receptor |
chr1_+_136467958 | 6.42 |
ENSMUST00000047817.6
|
Kif14
|
kinesin family member 14 |
chr2_+_103969528 | 6.34 |
ENSMUST00000123437.1
ENSMUST00000163256.1 |
Lmo2
|
LIM domain only 2 |
chr7_+_142460834 | 6.31 |
ENSMUST00000018963.4
ENSMUST00000105967.1 |
Lsp1
|
lymphocyte specific 1 |
chr11_+_70130329 | 6.27 |
ENSMUST00000041550.5
ENSMUST00000165951.1 |
Mgl2
|
macrophage galactose N-acetyl-galactosamine specific lectin 2 |
chr11_+_115899943 | 6.27 |
ENSMUST00000152171.1
|
Smim5
|
small integral membrane protein 5 |
chr8_+_84901928 | 6.21 |
ENSMUST00000067060.7
|
Klf1
|
Kruppel-like factor 1 (erythroid) |
chr2_+_22774081 | 6.18 |
ENSMUST00000014290.8
|
Apbb1ip
|
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
chr1_-_132367879 | 6.18 |
ENSMUST00000142609.1
|
Tmcc2
|
transmembrane and coiled-coil domains 2 |
chr2_+_84840612 | 6.17 |
ENSMUST00000111625.1
|
Slc43a1
|
solute carrier family 43, member 1 |
chr17_+_33555719 | 6.16 |
ENSMUST00000087605.5
ENSMUST00000174695.1 |
Myo1f
|
myosin IF |
chr3_+_96670131 | 6.15 |
ENSMUST00000048427.5
|
Ankrd35
|
ankyrin repeat domain 35 |
chr11_-_59163281 | 6.11 |
ENSMUST00000069631.2
|
Iba57
|
IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae) |
chr2_+_118111876 | 6.08 |
ENSMUST00000039559.8
|
Thbs1
|
thrombospondin 1 |
chrX_-_53240101 | 6.07 |
ENSMUST00000074861.2
|
Plac1
|
placental specific protein 1 |
chr11_+_115900125 | 6.06 |
ENSMUST00000142089.1
ENSMUST00000131566.1 |
Smim5
|
small integral membrane protein 5 |
chr5_-_73191848 | 6.04 |
ENSMUST00000176910.1
|
Fryl
|
furry homolog-like (Drosophila) |
chr11_-_6520894 | 6.00 |
ENSMUST00000003459.3
|
Myo1g
|
myosin IG |
chr11_+_61126747 | 5.98 |
ENSMUST00000010286.1
ENSMUST00000146033.1 ENSMUST00000139422.1 |
Tnfrsf13b
|
tumor necrosis factor receptor superfamily, member 13b |
chr11_-_102925086 | 5.95 |
ENSMUST00000021311.9
|
Kif18b
|
kinesin family member 18B |
chr3_-_20242173 | 5.94 |
ENSMUST00000001921.1
|
Cpa3
|
carboxypeptidase A3, mast cell |
chr9_+_65587187 | 5.91 |
ENSMUST00000047099.5
ENSMUST00000131483.1 ENSMUST00000141046.1 |
Pif1
|
PIF1 5'-to-3' DNA helicase homolog (S. cerevisiae) |
chr16_-_17144415 | 5.91 |
ENSMUST00000115709.1
|
Ccdc116
|
coiled-coil domain containing 116 |
chr11_-_115133981 | 5.88 |
ENSMUST00000106561.1
ENSMUST00000051264.7 ENSMUST00000106562.2 |
Cd300lf
|
CD300 antigen like family member F |
chr17_+_47505117 | 5.85 |
ENSMUST00000183044.1
ENSMUST00000037333.10 |
Ccnd3
|
cyclin D3 |
chr16_+_33794345 | 5.84 |
ENSMUST00000023520.6
|
Muc13
|
mucin 13, epithelial transmembrane |
chr16_+_33794008 | 5.82 |
ENSMUST00000115044.1
|
Muc13
|
mucin 13, epithelial transmembrane |
chr8_+_105297663 | 5.78 |
ENSMUST00000015003.8
|
E2f4
|
E2F transcription factor 4 |
chr14_-_55788810 | 5.74 |
ENSMUST00000022830.6
ENSMUST00000168716.1 ENSMUST00000178399.1 |
Ripk3
|
receptor-interacting serine-threonine kinase 3 |
chr2_-_181693810 | 5.72 |
ENSMUST00000108776.1
ENSMUST00000108771.1 ENSMUST00000108779.1 ENSMUST00000108769.1 ENSMUST00000108772.1 ENSMUST00000002532.2 |
Rgs19
|
regulator of G-protein signaling 19 |
chr15_+_66670749 | 5.64 |
ENSMUST00000065916.7
|
Tg
|
thyroglobulin |
chr17_+_34589799 | 5.64 |
ENSMUST00000038244.8
|
Gpsm3
|
G-protein signalling modulator 3 (AGS3-like, C. elegans) |
chr7_-_121074501 | 5.64 |
ENSMUST00000047194.2
|
Igsf6
|
immunoglobulin superfamily, member 6 |
chr4_+_120666562 | 5.63 |
ENSMUST00000094814.4
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr15_-_66801577 | 5.62 |
ENSMUST00000168589.1
|
Sla
|
src-like adaptor |
chr17_+_47505149 | 5.59 |
ENSMUST00000183177.1
ENSMUST00000182848.1 |
Ccnd3
|
cyclin D3 |
chr2_+_25423234 | 5.58 |
ENSMUST00000134259.1
ENSMUST00000100320.4 |
Fut7
|
fucosyltransferase 7 |
chr1_-_169531343 | 5.55 |
ENSMUST00000028000.7
|
Nuf2
|
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
chr10_-_62327757 | 5.53 |
ENSMUST00000139228.1
|
Hk1
|
hexokinase 1 |
chr15_+_57985873 | 5.51 |
ENSMUST00000050374.2
|
Fam83a
|
family with sequence similarity 83, member A |
chr11_+_103171081 | 5.47 |
ENSMUST00000042286.5
|
Fmnl1
|
formin-like 1 |
chr6_-_123289862 | 5.46 |
ENSMUST00000032239.4
ENSMUST00000177367.1 |
Clec4e
|
C-type lectin domain family 4, member e |
chr6_-_136941694 | 5.41 |
ENSMUST00000032344.5
|
Arhgdib
|
Rho, GDP dissociation inhibitor (GDI) beta |
chr3_+_84666192 | 5.38 |
ENSMUST00000107682.1
|
Tmem154
|
transmembrane protein 154 |
chr8_+_57511833 | 5.38 |
ENSMUST00000067925.6
|
Hmgb2
|
high mobility group box 2 |
chr7_+_110773658 | 5.36 |
ENSMUST00000143786.1
|
Ampd3
|
adenosine monophosphate deaminase 3 |
chr1_+_87620306 | 5.33 |
ENSMUST00000169754.1
|
Inpp5d
|
inositol polyphosphate-5-phosphatase D |
chr1_+_130731963 | 5.32 |
ENSMUST00000039323.6
|
AA986860
|
expressed sequence AA986860 |
chr8_+_48110156 | 5.31 |
ENSMUST00000174379.1
|
Dctd
|
dCMP deaminase |
chr12_+_32378692 | 5.30 |
ENSMUST00000172332.2
|
Ccdc71l
|
coiled-coil domain containing 71 like |
chr6_+_87778084 | 5.28 |
ENSMUST00000032133.3
|
Gp9
|
glycoprotein 9 (platelet) |
chr17_+_47505211 | 5.27 |
ENSMUST00000182935.1
ENSMUST00000182506.1 |
Ccnd3
|
cyclin D3 |
chr12_-_4841583 | 5.25 |
ENSMUST00000020964.5
|
Fkbp1b
|
FK506 binding protein 1b |
chr3_-_129969989 | 5.22 |
ENSMUST00000146340.1
|
Ccdc109b
|
coiled-coil domain containing 109B |
chr2_-_156839790 | 5.21 |
ENSMUST00000134838.1
ENSMUST00000137463.1 ENSMUST00000149275.2 |
Gm14230
|
predicted gene 14230 |
chr18_-_41951187 | 5.20 |
ENSMUST00000070949.4
|
Prelid2
|
PRELI domain containing 2 |
chr19_+_4154606 | 5.20 |
ENSMUST00000061086.8
|
Ptprcap
|
protein tyrosine phosphatase, receptor type, C polypeptide-associated protein |
chr2_-_13491900 | 5.19 |
ENSMUST00000091436.5
|
Cubn
|
cubilin (intrinsic factor-cobalamin receptor) |
chr9_-_14381242 | 5.17 |
ENSMUST00000167549.1
|
Endod1
|
endonuclease domain containing 1 |
chr1_+_87620334 | 5.15 |
ENSMUST00000042275.8
ENSMUST00000168783.1 |
Inpp5d
|
inositol polyphosphate-5-phosphatase D |
chr19_-_7019423 | 5.11 |
ENSMUST00000040772.8
|
Fermt3
|
fermitin family homolog 3 (Drosophila) |
chr2_-_73486456 | 5.06 |
ENSMUST00000141264.1
|
Wipf1
|
WAS/WASL interacting protein family, member 1 |
chr11_-_69602741 | 5.06 |
ENSMUST00000138694.1
|
Atp1b2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
chrX_-_49788204 | 5.05 |
ENSMUST00000114893.1
|
Igsf1
|
immunoglobulin superfamily, member 1 |
chr3_+_19644452 | 5.05 |
ENSMUST00000029139.7
|
Trim55
|
tripartite motif-containing 55 |
chr8_+_94977101 | 5.04 |
ENSMUST00000179619.1
|
Gpr56
|
G protein-coupled receptor 56 |
chr17_+_48247759 | 5.04 |
ENSMUST00000048065.5
|
Trem3
|
triggering receptor expressed on myeloid cells 3 |
chr8_+_48109949 | 5.03 |
ENSMUST00000170263.2
ENSMUST00000033966.6 |
Dctd
|
dCMP deaminase |
chr14_-_87141114 | 5.00 |
ENSMUST00000168889.1
|
Diap3
|
diaphanous homolog 3 (Drosophila) |
chr14_-_76556662 | 5.00 |
ENSMUST00000064517.7
|
Serp2
|
stress-associated endoplasmic reticulum protein family member 2 |
chr11_+_4236411 | 4.99 |
ENSMUST00000075221.2
|
Osm
|
oncostatin M |
chr7_+_100495987 | 4.95 |
ENSMUST00000133044.1
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr10_+_75564086 | 4.95 |
ENSMUST00000141062.1
ENSMUST00000152657.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr14_-_69284982 | 4.93 |
ENSMUST00000183882.1
ENSMUST00000037064.4 |
Slc25a37
|
solute carrier family 25, member 37 |
chr11_+_117782076 | 4.87 |
ENSMUST00000127080.1
|
Tmc8
|
transmembrane channel-like gene family 8 |
chr2_-_118728345 | 4.87 |
ENSMUST00000159756.1
|
Plcb2
|
phospholipase C, beta 2 |
chr7_+_79660196 | 4.86 |
ENSMUST00000035977.7
|
Ticrr
|
TOPBP1-interacting checkpoint and replication regulator |
chr14_-_33185489 | 4.86 |
ENSMUST00000159606.1
|
Wdfy4
|
WD repeat and FYVE domain containing 4 |
chr1_-_144775419 | 4.85 |
ENSMUST00000027603.3
|
Rgs18
|
regulator of G-protein signaling 18 |
chr1_+_135133272 | 4.84 |
ENSMUST00000167080.1
|
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr17_+_34605855 | 4.84 |
ENSMUST00000037489.8
|
Agpat1
|
1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha) |
chr17_-_32403551 | 4.84 |
ENSMUST00000135618.1
ENSMUST00000063824.7 |
Rasal3
|
RAS protein activator like 3 |
chr11_+_87760533 | 4.83 |
ENSMUST00000039627.5
ENSMUST00000100644.3 |
Bzrap1
|
benzodiazepine receptor associated protein 1 |
chr17_+_33638056 | 4.83 |
ENSMUST00000052079.7
|
Pram1
|
PML-RAR alpha-regulated adaptor molecule 1 |
chr3_+_95588960 | 4.82 |
ENSMUST00000176674.1
ENSMUST00000177389.1 ENSMUST00000176755.1 |
Golph3l
|
golgi phosphoprotein 3-like |
chr7_-_25615874 | 4.81 |
ENSMUST00000098663.1
|
Gm7092
|
predicted gene 7092 |
chr14_+_61309753 | 4.77 |
ENSMUST00000055159.7
|
Arl11
|
ADP-ribosylation factor-like 11 |
chr1_-_169531447 | 4.77 |
ENSMUST00000111368.1
|
Nuf2
|
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
chr18_+_61953048 | 4.76 |
ENSMUST00000051720.5
|
Sh3tc2
|
SH3 domain and tetratricopeptide repeats 2 |
chr11_+_11686213 | 4.75 |
ENSMUST00000076700.4
ENSMUST00000048122.6 |
Ikzf1
|
IKAROS family zinc finger 1 |
chr4_-_63403330 | 4.74 |
ENSMUST00000035724.4
|
Akna
|
AT-hook transcription factor |
chr9_-_111057235 | 4.72 |
ENSMUST00000111888.1
|
Ccrl2
|
chemokine (C-C motif) receptor-like 2 |
chr7_-_44748306 | 4.72 |
ENSMUST00000118162.1
ENSMUST00000140599.2 ENSMUST00000120798.1 |
Zfp473
|
zinc finger protein 473 |
chr3_+_95588990 | 4.71 |
ENSMUST00000177399.1
|
Golph3l
|
golgi phosphoprotein 3-like |
chr11_+_53519871 | 4.68 |
ENSMUST00000120878.2
|
Sept8
|
septin 8 |
chr15_-_78572754 | 4.66 |
ENSMUST00000043214.6
|
Rac2
|
RAS-related C3 botulinum substrate 2 |
chr15_+_85859689 | 4.65 |
ENSMUST00000170629.1
|
Gtse1
|
G two S phase expressed protein 1 |
chr4_-_43558386 | 4.65 |
ENSMUST00000130353.1
|
Tln1
|
talin 1 |
chr13_+_55369732 | 4.64 |
ENSMUST00000063771.7
|
Rgs14
|
regulator of G-protein signaling 14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.1 | 48.2 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
11.5 | 34.6 | GO:0070488 | neutrophil aggregation(GO:0070488) |
6.7 | 20.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
6.7 | 20.1 | GO:0035702 | monocyte homeostasis(GO:0035702) |
6.7 | 20.1 | GO:0030221 | basophil differentiation(GO:0030221) |
5.2 | 15.6 | GO:0002215 | defense response to nematode(GO:0002215) |
4.4 | 4.4 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
4.3 | 17.0 | GO:0051311 | spindle assembly involved in female meiosis(GO:0007056) meiotic metaphase plate congression(GO:0051311) |
4.2 | 12.6 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
4.0 | 12.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
3.7 | 14.9 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
3.7 | 11.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
3.5 | 17.7 | GO:0071104 | response to interleukin-9(GO:0071104) |
3.4 | 10.3 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
3.1 | 9.4 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
2.9 | 8.7 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
2.9 | 5.7 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
2.7 | 13.7 | GO:2000473 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
2.7 | 13.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
2.7 | 19.1 | GO:0070942 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
2.6 | 7.8 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.5 | 19.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.5 | 14.8 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
2.5 | 12.3 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
2.4 | 24.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.4 | 2.4 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
2.4 | 9.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.4 | 9.4 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
2.4 | 16.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
2.3 | 9.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.2 | 6.6 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
2.2 | 10.9 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
2.2 | 6.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
2.1 | 6.4 | GO:0033624 | negative regulation of integrin activation(GO:0033624) |
2.1 | 23.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
2.1 | 8.5 | GO:0045575 | basophil activation(GO:0045575) |
2.0 | 6.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
2.0 | 28.0 | GO:0033572 | transferrin transport(GO:0033572) |
1.9 | 5.8 | GO:2000196 | positive regulation of female gonad development(GO:2000196) positive regulation of progesterone secretion(GO:2000872) |
1.9 | 13.5 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.9 | 1.9 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.9 | 13.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.8 | 3.6 | GO:0071611 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
1.8 | 5.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.7 | 22.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.7 | 5.0 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
1.7 | 6.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.7 | 6.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.6 | 8.2 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
1.6 | 3.2 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
1.6 | 14.4 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
1.6 | 7.8 | GO:0042117 | monocyte activation(GO:0042117) |
1.5 | 11.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.5 | 11.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.4 | 2.9 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
1.4 | 5.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.4 | 7.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.4 | 2.8 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.4 | 4.1 | GO:0015866 | ADP transport(GO:0015866) |
1.4 | 4.1 | GO:0010716 | regulation of collagen catabolic process(GO:0010710) negative regulation of extracellular matrix disassembly(GO:0010716) |
1.4 | 27.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.4 | 4.1 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
1.4 | 1.4 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
1.3 | 5.4 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.3 | 10.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.3 | 18.7 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
1.3 | 18.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
1.3 | 17.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
1.3 | 15.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.3 | 11.7 | GO:0032264 | IMP salvage(GO:0032264) |
1.3 | 6.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.3 | 3.9 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.3 | 11.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.3 | 5.1 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.3 | 5.0 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
1.3 | 3.8 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
1.2 | 3.7 | GO:0048478 | replication fork protection(GO:0048478) |
1.2 | 2.5 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
1.2 | 9.7 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.2 | 8.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.2 | 7.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
1.2 | 3.6 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
1.2 | 3.6 | GO:0007521 | muscle cell fate determination(GO:0007521) |
1.2 | 7.1 | GO:0032796 | uropod organization(GO:0032796) |
1.2 | 15.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.2 | 14.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
1.2 | 5.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.2 | 3.5 | GO:0006404 | RNA import into nucleus(GO:0006404) mRNA export from nucleus in response to heat stress(GO:0031990) negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
1.2 | 29.1 | GO:0045730 | respiratory burst(GO:0045730) |
1.1 | 2.3 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
1.1 | 3.4 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.1 | 1.1 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
1.1 | 11.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.1 | 6.6 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
1.1 | 9.9 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.1 | 5.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.1 | 3.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.1 | 1.1 | GO:0036269 | swimming behavior(GO:0036269) |
1.1 | 6.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.1 | 2.1 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
1.1 | 4.2 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
1.0 | 8.4 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
1.0 | 1.0 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
1.0 | 6.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
1.0 | 11.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.0 | 2.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
1.0 | 5.2 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.0 | 2.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.0 | 5.1 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
1.0 | 3.0 | GO:1905204 | negative regulation of connective tissue replacement(GO:1905204) |
1.0 | 3.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
1.0 | 2.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
1.0 | 4.0 | GO:0006014 | D-ribose metabolic process(GO:0006014) pentose catabolic process(GO:0019323) |
1.0 | 5.9 | GO:0060931 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
1.0 | 2.9 | GO:0070315 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) G1 to G0 transition involved in cell differentiation(GO:0070315) |
1.0 | 5.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.0 | 4.8 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
1.0 | 3.8 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.0 | 1.0 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.9 | 10.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.9 | 13.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.9 | 0.9 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.9 | 2.7 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.9 | 10.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.9 | 2.6 | GO:0002344 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.9 | 8.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.9 | 3.4 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.9 | 2.6 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.9 | 6.0 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.8 | 1.7 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.8 | 0.8 | GO:0003284 | septum primum development(GO:0003284) |
0.8 | 6.7 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.8 | 0.8 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.8 | 4.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.8 | 3.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.8 | 7.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.8 | 2.4 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.8 | 5.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.8 | 3.2 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.8 | 5.6 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.8 | 4.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.8 | 7.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.8 | 7.0 | GO:0015705 | iodide transport(GO:0015705) |
0.8 | 2.3 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.8 | 2.3 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.8 | 2.3 | GO:0032685 | regulation of interleukin-18 production(GO:0032661) negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) negative regulation of interleukin-18 production(GO:0032701) |
0.8 | 3.9 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.8 | 3.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.8 | 3.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.8 | 3.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.8 | 3.8 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.8 | 2.3 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.8 | 1.5 | GO:0048295 | T-helper 1 cell lineage commitment(GO:0002296) positive regulation of isotype switching to IgE isotypes(GO:0048295) positive regulation of mononuclear cell migration(GO:0071677) |
0.7 | 5.2 | GO:0051775 | response to redox state(GO:0051775) |
0.7 | 4.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.7 | 3.0 | GO:0044849 | estrous cycle(GO:0044849) |
0.7 | 5.2 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.7 | 1.5 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.7 | 2.2 | GO:1904732 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.7 | 4.4 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.7 | 16.7 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.7 | 2.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.7 | 8.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.7 | 4.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.7 | 2.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.7 | 3.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.7 | 5.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.7 | 1.4 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.7 | 2.8 | GO:0060032 | notochord regression(GO:0060032) |
0.7 | 5.6 | GO:1904378 | maintenance of unfolded protein(GO:0036506) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.7 | 9.0 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.7 | 2.8 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.7 | 2.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.7 | 7.5 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.7 | 1.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.7 | 2.0 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.7 | 5.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.7 | 5.3 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.7 | 3.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.6 | 2.5 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.6 | 5.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.6 | 3.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.6 | 2.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) leading strand elongation(GO:0006272) |
0.6 | 6.9 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.6 | 3.8 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.6 | 2.5 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.6 | 3.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 0.6 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
0.6 | 1.2 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.6 | 3.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.6 | 3.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.6 | 4.9 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.6 | 3.7 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.6 | 2.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.6 | 6.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.6 | 0.6 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.6 | 3.0 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.6 | 6.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.6 | 4.8 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.6 | 1.8 | GO:0010513 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.6 | 10.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.6 | 1.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.6 | 4.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.6 | 5.9 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.6 | 4.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.6 | 1.8 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.6 | 1.7 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.6 | 14.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.6 | 1.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.6 | 8.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.6 | 2.9 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.6 | 1.7 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.6 | 7.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.6 | 4.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.6 | 1.7 | GO:0050705 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) regulation of interleukin-1 alpha secretion(GO:0050705) |
0.6 | 2.8 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.6 | 1.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.6 | 2.2 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.6 | 1.7 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.6 | 2.8 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.5 | 9.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.5 | 1.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.5 | 3.3 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.5 | 7.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.5 | 6.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.5 | 3.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 32.2 | GO:0070527 | platelet aggregation(GO:0070527) |
0.5 | 1.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.5 | 12.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.5 | 0.5 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
0.5 | 4.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 6.4 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.5 | 2.1 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.5 | 3.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.5 | 3.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.5 | 1.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.5 | 2.0 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.5 | 3.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.5 | 2.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.5 | 1.5 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.5 | 1.0 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.5 | 4.0 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.5 | 1.5 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.5 | 1.5 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.5 | 7.5 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 2.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.5 | 2.0 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
0.5 | 2.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.5 | 11.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.5 | 1.9 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.5 | 4.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.5 | 1.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.5 | 6.1 | GO:0001553 | luteinization(GO:0001553) |
0.5 | 6.6 | GO:0015747 | urate transport(GO:0015747) |
0.5 | 0.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.5 | 7.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 0.9 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.5 | 2.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 2.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.5 | 3.7 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.5 | 2.7 | GO:0010039 | response to iron ion(GO:0010039) |
0.5 | 2.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.5 | 7.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.5 | 1.8 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.4 | 4.5 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.4 | 0.9 | GO:1901738 | regulation of vitamin A metabolic process(GO:1901738) |
0.4 | 1.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.4 | 0.4 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.4 | 2.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 1.7 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.4 | 2.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 0.9 | GO:0010286 | heat acclimation(GO:0010286) |
0.4 | 1.7 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.4 | 1.3 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.4 | 1.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.4 | 1.3 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.4 | 11.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 2.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.4 | 1.3 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.4 | 0.8 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.4 | 1.3 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 2.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.4 | 2.9 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.4 | 9.6 | GO:0097320 | membrane tubulation(GO:0097320) |
0.4 | 1.3 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.4 | 7.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.4 | 1.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.4 | 3.3 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.4 | 5.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 2.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 13.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.4 | 3.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 1.2 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.4 | 1.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.4 | 1.2 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.4 | 1.2 | GO:2000314 | negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.4 | 2.0 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.4 | 2.0 | GO:0019516 | lactate oxidation(GO:0019516) |
0.4 | 1.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 1.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.4 | 2.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.4 | 3.8 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.4 | 3.4 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.4 | 1.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.4 | 1.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.4 | 2.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 4.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 0.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.4 | 0.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.4 | 1.5 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.4 | 0.7 | GO:2000583 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.4 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 1.5 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.4 | 4.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.4 | 2.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.4 | 2.1 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.4 | 3.6 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.4 | 1.4 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.3 | 0.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 2.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 4.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 0.7 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.3 | 1.0 | GO:0036302 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) olfactory nerve development(GO:0021553) atrioventricular canal development(GO:0036302) |
0.3 | 2.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.3 | 1.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 2.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.3 | 8.7 | GO:0001562 | response to protozoan(GO:0001562) |
0.3 | 3.0 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.3 | 1.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 1.0 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.3 | 1.6 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 1.3 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.3 | 1.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 0.9 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 1.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 2.5 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 1.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 1.5 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.3 | 3.4 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.3 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 3.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 4.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.3 | 1.8 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 2.1 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.3 | 1.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.3 | 0.9 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.3 | 0.6 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.3 | 0.9 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 2.0 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.3 | 0.3 | GO:0001802 | antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.3 | 1.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 1.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 2.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 2.8 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.3 | 1.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.3 | 0.3 | GO:0061010 | gall bladder development(GO:0061010) |
0.3 | 0.5 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.3 | 1.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.3 | 1.9 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 1.9 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 2.6 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 0.8 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 1.3 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.3 | 1.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 0.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 0.3 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.3 | 4.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 1.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 1.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 1.3 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.3 | 2.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 0.8 | GO:1901355 | response to rapamycin(GO:1901355) |
0.2 | 1.7 | GO:1905216 | positive regulation of RNA binding(GO:1905216) |
0.2 | 0.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 1.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 4.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 1.0 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.2 | 0.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 4.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 9.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 3.9 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 2.2 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 0.7 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 1.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 1.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.7 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.2 | 9.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 1.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 1.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 9.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 1.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.2 | 2.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 1.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 2.1 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.2 | 0.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) positive regulation of protein lipidation(GO:1903061) |
0.2 | 7.0 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 2.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 | 0.7 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.9 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.2 | 3.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 0.7 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.2 | 0.4 | GO:2000043 | regulation of cardiac cell fate specification(GO:2000043) |
0.2 | 1.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 2.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 3.7 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.7 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 2.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 2.6 | GO:0032528 | microvillus organization(GO:0032528) |
0.2 | 8.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 1.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 1.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.4 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 0.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.4 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 1.3 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.2 | 0.4 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 1.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 1.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 8.2 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 1.4 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 6.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 4.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.8 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.2 | 3.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 1.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.0 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.2 | 1.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 0.6 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.2 | 0.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA processing(GO:0090646) |
0.2 | 0.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 1.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 1.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.6 | GO:0090297 | positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) positive regulation of mitochondrial DNA metabolic process(GO:1901860) stress-induced mitochondrial fusion(GO:1990046) |
0.2 | 0.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 1.1 | GO:0052205 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 2.9 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 2.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.9 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.2 | 1.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 2.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 3.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.9 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 1.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.7 | GO:1902477 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.2 | 0.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 0.5 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.2 | 1.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 1.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 1.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 2.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 2.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 0.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 1.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 1.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 2.9 | GO:0099612 | protein localization to axon(GO:0099612) |
0.2 | 1.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 1.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 2.7 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 5.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 1.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.5 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.2 | 4.4 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 0.6 | GO:0099639 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
0.2 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 6.0 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.2 | 1.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 4.1 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.2 | 1.7 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 1.6 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 1.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 2.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 3.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.3 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.2 | 0.5 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 2.3 | GO:0098801 | regulation of renal system process(GO:0098801) |
0.2 | 6.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 0.5 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 5.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.9 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.4 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 0.9 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.7 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
0.1 | 2.0 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 1.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 2.7 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.8 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.1 | 4.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.8 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 4.1 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.4 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.1 | 2.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.8 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.9 | GO:0001840 | neural plate development(GO:0001840) |
0.1 | 0.8 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.4 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.1 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 1.5 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 1.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 4.6 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.9 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 2.0 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.8 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.1 | 0.3 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 0.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.8 | GO:2001170 | negative regulation of dopamine secretion(GO:0033602) negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 4.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 1.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 1.2 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.1 | 0.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 1.4 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 1.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 7.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.4 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 2.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 1.0 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 1.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.1 | 3.2 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.1 | 2.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.8 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.1 | 3.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.6 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.6 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.1 | 1.9 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.6 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.2 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 0.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 4.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 1.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.8 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 7.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 4.2 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.7 |